drugset / Trial / NCT03490708

A Clinical Study of Tranilast in the Treatment of Mucinoses

NCT03490708

NaSingle-groupOpen-labelTreatment

Summary

56 participants with Mucinoses will be selected to receive treatment of tranilast. After a period of time ,the investigators can determine the efficacy of the drug by detecting the the thickness and area of skin before and after treatment.

Timeline

Start
2018-04
Primary completion
2022-06
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranilast Small molecule 0.1 g

Indications